DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20200882

Polycystic ovarian syndrome among adolescent and young women: a hospital based observational study in a tertiary care teaching Hospital

Arpita Jain, Swati Garg, Urvashi Sharma

Abstract


Background: Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorder among women of fertile age. The incidence of PCOS as claimed by various observer ranges from 2.2% to as high as 26%. India is considered as an emerging epidemic area for PCOS and limited studies are done. Hence aim of this study is to find the prevalence of PCOS and determine the associated determining factors in adolescent girls.

Methods: All the girls aged 15-24 years were approached and after undergoing detailed history, examination and investigations were further diagnosed as PCOS. The study subjects were then classified into two group: the PCOS and non-PCOS group and compared to determine significant differences as per the Rotterdam criteria.

Results: The prevalence of PCOS was 7.5%, 18.68% and 11.18% as per NIH, Rotterdam and AES criteria respectively. BMI more than 30, waist circumference > 80 cm, hyperandrogenic manifestations, menstrual irregularity (oligomenorrhea) and family history of PCOS and DM showed statistically significant association with PCOS. Serum LH, LH/FSH ratio, S. Testosterones, serum insulin and HOMA-IR had significant association with PCOS. No significant association of Fasting blood sugar levels and deranged lipid profile was found with PCOS.

Conclusions: PCOS is an emerging disorder during adolescents and hence awareness creation, early screening in order to inculcate early life style modifications and prevent metabolic and reproductive complications of this disease.


Keywords


HOMA-IR, Polycystic ovarian syndrome, Rotterdam, Serum insulin

Full Text:

PDF

References


Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metabol. 2014;18(3):317-24.

Radha P, Devi RS, Madhavi J. Comparative study of prevalence of polycystic ovarian syndrome in rural and urban population. J Adv Med Dent Sci Res. 2016;4(2):90.

Nidhi R, Padmalata V. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Paediatr Adolescents Gynecol. 2011;24(4):223-7.

Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: a community-based study. Indian J Endocrinol Metabol. 2012;16 (Suppl 2):S389-S392.

Toulis KA, Goulis DG, Kolibianakis EM, Venetis CA, Tarlatzis BC, Papadimas I. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil Steril. 2009;92(2):667-77.

Malik S, Jain K, Talwar P, Prasad S, Dhorepatil B, Devi G, et al. Management of polycystic ovary syndrome in India. Fertil Sci Res. 2014;1:23-43.

Patil M. Pathophysiology of PCOS. The PCOS Society of India Newsletter. PANDORA. 2016;1:6-8.

Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90:4650-8.

Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications; 1992:377-384.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Androgen excess society. Position statement: criteria for defining PCOS as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237-45.

Upadhya RS, Tripathy S, Mohapatra S. Prevalence of poly cystic ovarian syndrome among students of a tertiary care teaching hospital. Indian J Obstet Gynecol Res. 2018;5(4):481-4.

Singh A, Vijaya K, Laxmi KS. Prevalence of polycystic ovarian syndrome among adolescent girls: a prospective study. Int J Reprod Contracept Obstet Gynecol. 2018;7:4375-8.

Desai NA, Tiwari RY, Patel SS. Prevalence of polycystic ovary syndrome and its associated risk factors among adolescent and young girls in Ahmedabad Region. Indian J Pharma Pract. 2018;11(3):119.

Choudhary A, Jain S, Chaudhari P. Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence. Inter J Reprod Contra Obstet Gynecol. 2017;6(11):4971-5.

Sangabathula H, Varaganti N. Clinical profile polycystic ovarian syndrome - 100 cases. Int J Conte Med Res. 2017;4(6):1249-53.

Laxmi - Lakshmi KS, Jayasutha J, Chandrasekar A. A study on prevalence of polycystic ovary syndrome at a tertiary care hospital. Int J Pharm Sci Res. 2015;6(1):383-5.

Sunita J, Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, et al. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocr Metab. 2013;17:138-45.

Begum GS, Shariff A, Ayman G, Mohammad B, Housam R, Khaled N. Assessment of risk factors for development of polycystic ovarian syndrome. Int J Conte Med Res. 2017;4(1):164-7.

Kumarapeli V, Seneviratne RD, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol. 2008;168:321-8.

Hashemi AH, Mozdarani H, Naghavi A. Comparison of the Levels of LH and FSH, TSH, Prolactin, progesterone and estradiol hormones between Iranian infertile women with polycystic ovary syndrome and healthy women. Int J Med Res Health Sci. 2016;5(12):370-5.

Gupta V, Sharma S, Raina SK, Bedi GK. Clinical, ultrasonographic, and biochemical correlates of polycystic ovarian syndrome: a case-control study from a tertiary care center in North India. J Sci Soc. 2018;45:8-12.

Thangavelu M, Godla UR, Godi S, Paul SF, Maddaly R. A case-controlled comparative hospital-based study on the clinical, biochemical, hormonal, and gynecological parameters in polycystic ovary syndrome. Indian J Pharm Sci. 2017;79(4):608-16.

Alebić MŠ, Bulum T, Stojanović N, Duvnjak L. Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria. Endocrine. 2014;47(2):625-30.

Amini L, Sadeghi MR, Oskuie F, Kamali K, Maleki H. Lipid profile in women with polycystic ovary syndrome. Crescent J Med Biol Sci. 2014;1(4):147-50.

Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril. 2009;92(2):626-34.

Esmaeilzadeh S, Andarieh MG, Ghadimi R, Delavar MA. Body mass index and gonadotropin hormones (LH and FSH) associate with clinical symptoms among women with polycystic ovary syndrome. Global J Health Sci. 2015;7(2):101.